Skip to main content

How RNA Sequencing Can Help Improve Diagnosis of Rare Diseases?

 

RNA sequencing is a genomic approach for the identification and quantification analysis of RNA molecules with the ultimate aim of studying cellular responses from a biological sample. The advent of RNA sequencing had fueled several innovations in the medical sector, by facilitating other techniques (that utilize RNA sequencing) such as single nucleotide polymorphisms identification, RNA editing, transcriptional profiling and differential gene expression analysis.

RNA sequencing offers massive diagnostic utility in terms of rare diseases, which ranges from rare muscular disorders to mitochondrial diseases such as mitochondrial depletion syndrome, Leigh’s syndrome, and Kearns-Sayre syndrome, among others. RNA sequencing is an emerging technique to assess progression of different rare diseases. It aids medical professionals to understand various genes linked with specific rare diseases, thereby offering specific treatment for patients.

The rise in the discovery of genes associated with rare diseases coupled with the declining cost of genome sequencing is anticipated to enhance research in the rare disease segment. This is likely to support sequencing, particularly RNA sequencing, in the upcoming years.

Based on the market intelligence published by BIS Research, titled “Global RNA Sequencing Market - Analysis and Forecast, 2019-2028”, the market is expected grow at a significant CAGR of 14.21% during the forecast period, 2019-2028. This growth is driven by factors including increasing adoption of personalized medicine due to decreasing cost of sequencing and increasing utility in predictive biomarkers and therapeutic response research.

Further, amongst the various applications of the RNA sequencing, including drug discovery, translation medicine, diagnostics, and other, the drug discovery segment emerges as a prominent segment. The segment contributed approximately 44.50% share in 2018 and is expected to cover a significant share in the application segment in 2028. This segment is driven by the increase in use of RNA sequencing to modify drugs to suit the requirements of a specific patient owing to the incorporation of precision medicine.

In the RNA sequencing segment, there are several needs that are yet to be addressed by the stakeholders present in the market. These needs are related to shortage of skilled professionals in the field of bioinformatics and genomics. To fulfil this shortage of skilled professionals, regulations for quality analysis and interpretation of sequencing results are required to be established.

Comments

Popular posts from this blog

Chatbots Increasing Efficiency in Healthcare Market

Chatbots are one of the prominent technologies currently being integrated into the healthcare system. The chatbots are not considered as the SaMD (software as medical device) as they do not participate in clinical decision-making process, rather, they act as the personal healthcare assistant as well as the trainer for its users. Click Here To Get Detailed Description of  Chatbots in Healthcare Market The usage of chatbots in the healthcare has gained popularity since 2013, when Babylon Health, the first healthcare chatbot company of the U.K. was launched. The company offered symptom checker chatbot and has started using the same chatbot as a health checker as well. The industry comprises the bot developers, platform providers, content providers, and the interface providers. Since there are no regulatory bodies such as FDA and MHRA directly governing the usage of chatbots, launching the chatbot is convenient for the developers. New start-ups are coming up wit...

Wireless Charging Technology – Analyzing the Market Drivers and Restraints

Wireless charging technology eliminates the use of wires to power devices and enables a device to be charged automatically when placed near a transmitter. The wireless charging technology is however, not new in the world of technology, rather, has been in existence since the late 1800s. With the incorporation of the technology in smartphones, it has been experiencing a massive boost in popularity. Request the Sample @  https://bisresearch.com/requestsample?id=645&type=download According to the latest market intelligence report by BIS Research titled “ Global Wireless Charging Market - Analysis and Forecast (2018-2023) ,” the market was valued at $2.58 billion in 2017 and is projected to grow at a CAGR of 40.97%, during the forecast period and reach $20.97 billion by 2023.  The market is estimated to witness the highest growth in the Asia-Pacific (APAC) region during the forecast period (2018-2023). The wireless charging technology is not only limited to the sm...

Analyzing the Growth and Expansion of the Neurostimulation Devices Market

The global healthcare economic burden, at present, is primarily characterized by major contributors such as chronic pain and neurological disorders. The annual societal cost for chronic pain and neurological disorders accounted for $635 billion and $789 billion respectively in the U.S., in 2014. Opioids are one of the most preferred medicines for the treatment of chronic pain, however, the side-effects associated with opioids have resulted in a decline in their overall usage and sale. Consequently, the increasing cases of neurological disorders and the need for a novel approach for the treatment of such diseases has led to the advent of neuromodulation technologies. The rapid shift of the healthcare industry toward neurostimulation devices from opioids and other conventional treatment techniques can be attributed to the efficient, safe, and targeted approach of neurostimulation devices. BIS Research recently published a market intelligence report titled “ Global Neurostim...